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Abstract
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second-hand cannabis smoke while working in the community. Emerging evidence suggests the benefits of
cannabis in the treatment of several chronic and terminal illnesses. This has led to some countries, like
Australia, decriminalising or legalising the use of cannabis for medicinal purposes. Smoked cannabis is one of
several routes of administration. However, cannabis smoke may have an impact on those in close proximity to
the consuming patient. As a result, community healthcare workers, including nurses, may passively inhale
cannabis substances while visiting patients in their home. This poses a work health and safety risk to the
community nurses and other healthcare workers. This review intends to raise awareness of this fact and reveals
that more research and education is needed to strengthen policies and procedures around the nursing
practices in the care of patients who choose to use smoked medicinal cannabis for symptom management. The
successful use of cannabis in the treatment of a range of chronic or terminal medical conditions, such as
chemotherapy-induced nausea and vomiting, palliative care patients or childhood epilepsy, is currently widely
discussed and reported around in the media and specialised literature (Suraev et al. 2017; Wong & Wilens
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The effects and impact of
second-hand cannabis smoke
exposure on nurses working in
the community

By Dr Miguel A Iglesias, Joy Pertile,
Luke Molloy and Alex Chan

ABSTRACT:
This article explores the work, health and
safety risks that may be associated with
the exposure of nurses to second-hand
cannabis smoke while working in the
community. Emerging evidence suggests
the benefits of cannabis in the treatment
of several chronic and terminal illnesses.
This has led to some countries, like
Australia, decriminalising or legalising the
use of cannabis for medicinal purposes.
Smoked cannabis is one of several routes
of administration. However, cannabis
smoke may have an impact on those in
close proximity to the consuming patient.
As a result, community healthcare
workers, including nurses, may passively
inhale cannabis substances while visiting
patients in their home. This poses a work
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health and safety risk to the community
nurses and other healthcare workers.
This review intends to raise awareness of
this fact and reveals that more research
and education is needed to strengthen
policies and procedures around the
nursing practices in the care of patients
who choose to use smoked medicinal
cannabis for symptom management.
The successful use of cannabis in the
treatment of a range of chronic or
terminal medical conditions, such as
chemotherapy-induced nausea and
vomiting, palliative care patients or
childhood epilepsy, is currently widely
discussed and reported around in
the media and specialised literature
(Suraev et al. 2017; Wong & Wilens
2017; Hausman-Kedem & Kramer 2017;
Abrams 2018). The use and cultivation of
cannabis for any purposes in Australia,
including medical research for acute and
chronic disease management, has been
prohibited since the early twentieth
century (Rodman 2015).

OVERVIEW OF THE ISSUE:
Possession of cannabis is illegal in most
countries, and even the death penalty
may apply for the sale and possession of
cannabis in some countries (Edwards et al.
2011). In general, the negative portrayal of
cannabis is not only associated with drug
addiction and health behavioural issues
(Agrawal et al. 2016; Agrawal & Lynskey 2006;
Agrawal et al. 2017), but also associated with
criminal offences by the media and general
public (Pedersen & Skardhamar 2010; Morris
et al. 2014).
However, emerging evidence suggesting the
usefulness of cannabis as medical therapy,
and the increase in patients supported
who are suffering these conditions in the
community has led several countries,
including Australia, towards legalising or
decriminalising the use of cannabis for
medicinal purposes.
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RISKS TO HEALTH IN
THE TARGET GROUP
(COMMUNITY NURSES):
While smoking cannabis is not a route of
administration supported by the Australian
Therapeutic Goods Administration, patients
may choose to inhale cannabis smoke as a
treatment modality at home, unaware that
this may pose a work health and safety risk
to the nurses and other healthcare workers
who visit patients in the community.

PROJECT OUTLINE:
This article represents a synthesis of
relevant literature for nursing practice
exploring the effects and possible impact of
second-hand medicinal cannabis smoking
on nurses working in the community. The
authors examine key findings identified
and provide analysis of their relevance to
nursing and healthcare workers working in
the community.
A literature review was undertaken to
find publications related to second-hand
cannabis smoke. The databases searched
were Web of Science, Scopus and CINAHL.
The search terms used were cannab* OR
marijuana AND (“secondhand” OR “secondhand” OR “second hand”) AND smok*. A
total of 88 papers were identified across
the search: CINAHL (42), Web of Science (9)
and SCOPUS (36). The search highlighted
a limited evidence based on the impact of
second-hand cannabis smoke on human
subjects. There was no primary research
on health professionals’ exposure to
second-hand cannabis smoke, using either
qualitative or quantitative methods.

RESULTS
THE EFFECTS OF
CANNABIS SMOKE
With the increased use of cannabis, there
has been a growing concern about its
possible adverse effects. While there are a
variety of modes of delivery, the fastest route
of absorption of the active components of
cannabis, tetrahydrocannabinol (THC) and
cannabidiol (CBD), is via the respiratory
system (Grotenhermen 2003). Thus, smoked
cannabis is the most common form of
consumption of cannabis for recreational
use (Newmeyer et al. 2017).
Although smoking cannabis is the only
route of administration not recommended
by the Australian Therapeutics Goods
Administration due to the harmful effects of
smoke, its fast absorption (Grotenhermen
2003) could facilitate the titration when

used for medicinal purposes, and may be
the chosen route by the patient looking
for fast symptom relief. Cannabis can be
smoked alone, but it is most regularly mixed
with tobacco (Meier & Hatsukami 2016).
Smoke from both cannabis and tobacco
contains a mixture of compounds,
including carcinogenic molecules and tars
known to be the culprit of damaging effects
of smoking (Hoffmann et al. 2001), although
to differing degrees depending on which
substance is smoked (Melamede 2005).
A logical inference is that the effects
of cannabis smoke could also affect
second-hand smokers (Holitzki et al. 2017),
including nurses working in the community
who may unconsciously and/or passively
be exposed at times to the smoke of
cannabis.
THC is the compound in cannabis that
causes hallucinogenic results (Johannigman
& Eschiti 2013). The THC from a typical
cannabis cigarette that is absorbed by the
mainstream smoker is found to be in the
range of 20-37%.
Pyrolysis further destroys approximately
30% of the THC and the remaining 40-50%
is released as side-stream smoke into the
environment. In addition, there are further
contaminants from the exhalation of the
mainstream smoke. Therefore, regardless
of the many factors that affect absorption
of THC, there is a likelihood of passive
inhalation of THC in non-smokers in an
environment where cannabis is being
smoked (Berthet et al. 2016).

HEALTH RISKS OF SECONDHAND CANNABIS SMOKE
The effect of second-hand cannabis
smoke (SHCS) must be considered in the
discussion of using cannabis products as
a treatment modality in the community.
SHCS is defined as a combination of the
side-stream smoke that is emitted from the
cannabis cigarette and the exhaled smoke
from the mainstream smoker (Office on
Smoking and Health 2006). The effects of
second-hand tobacco smoking have been
extensively investigated. It is known that
non-smokers exposed to second-hand
smoke from tobacco have a 30% increased
risk of cerebral vascular attack (CVA) (Malek
et al. 2015), and that it can affect cognitive
function (Heffernan & O’Neill 2013) and
even future dependence (Wilson-Frederick
et al. 2011).
However, the effects of SHCS are less well
known due to cannabis being illegal until
recently in most countries, which made
research difficult to conduct.

SHCS from combustible cannabis has
similar health risks to second-hand tobacco
smoke due to the combustive organic
material, which creates carcinogenic
and mutagenic effects (Cone et al. 2015a).
Cannabis contains many of the same toxins
in tobacco, which are responsible for
cardiovascular damage. In fact, many toxins
such as ammonia, nitric oxide and hydrogen
cyanide, are found in levels between three
to 20 times higher in cannabis than in
tobacco (American Chemical Society 2007).
Studies in rodents (Wang et al. 2016) have
demonstrated that exposure to cannabis
smoke for as little as one minute impairs
cardiovascular function for the following
90 minutes. Long-term effects of repeated
endothelial dysfunction can lead to
cardiovascular disease including thrombus
formation, CVA and myocardial infarction
(Rajendran et al. 2013).
The study by Wang et al. (2016) also noted
a longer deleterious cardiovascular effect
after second-hand exposure to smoke
from cannabis versus tobacco. This is a
very significant finding, because the nurse
visiting a patient who may be smoking
cannabis for medicinal purposes would
most likely be exposed for more than
60 seconds. In attempts to decrease the
THC levels, and thus the hallucinogenic
effects, of medical cannabis by changing
environmental factors, the study found
that the endothelial dysfunction was
independent of the level of THC of the
cannabis (Wang et al. 2016). Thus, even if
medicinal cannabis has reduced levels of
THC, SHCS exposure may still affect the
nurse’s endothelial function.
In humans, subjective drug effects of
cannabis smoke inhaled passively have
been found to be dose-dependent (Cone et
al. 2015b). Therefore the impact on health
practitioners of SHCS used by patients
should not be underestimated, particularly
since few health providers, including
nurses, felt completely knowledgeable
about marijuana (cannabis) health risks
(Brooks et al. 2017), and may not avoid
exposure during their home visit to patients
utilising smoked medical cannabis.
A question that often arises is whether SHCS
will cause blood levels to be high enough
to test positive in the nurse who is exposed
and if so, what effect may that have on the
nurse’s cognition? Hours after secondary
exposure to cannabis smoke, THC can be
detected in screening tests of urine (Cone
et al. 2015a) and oral fluids (Cone et al.
2015b), although only after exposure to high
smoke concentrations. However, adequate
room ventilation may reduce the level of
secondary exposure to cannabis compounds
(Herrmann et al. 2015; Cone et al. 2015a).
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all practitioners with substance related
impairment (AHPRA 2015). These nurses
have routine hair and urine testing of a
wide range of drugs, not just based on
the nurse’s drug taking history (AHPRA
2015). Moosmann et al. (2014) have noted
that ‘considering the severe consequences
people concerned may experience,
contamination issues in hair analysis still do
not seem to be investigated to an extent that
would be desirable’ (p.125).

A question that often
arises is whether SHCS
will cause blood levels
to be high enough to test
positive in the nurse who
is exposed and if so,
what effect may that have
on the nurse’s cognition?

This is an important issue that health
practitioners should pay attention to when
carrying out their duty at the patients’
home. A study conducted by Cone et
al. (2015a) demonstrated that shortterm exposure to cannabis smoke in an
unventilated space produced absorption of
sufficient amounts of THC for non-smokers
to test positive for THC up to three hours
following exposure. In their systematic
review of passive exposure to cannabis
smoke, Berthet et al. (2016) advised ‘experts
should clearly inform persons who have
to demonstrate prolonged abstinence
from cannabis to avoid heavily smoky
and unventilated areas’ (p. 110). Similarly,
Holitzki et al. (2017) also recommend that
clinicians advise cannabis users to smoke
only in open outdoor spaces due to the
effects of SHCS. This research would seem
to indicate the need for nurses to avoid
exposure to cannabis smoke in unventilated
spaces, not just for potential negative
implications on their health, but also
potential legal implications. It also poses
the question as to how this may impact
a nurse’s performance as well as driving
ability after visiting a patient who has been
smoking medical cannabis during the visit.

POTENTIAL WORK HEALTH
AND SAFETY RISKS TO THE
COMMUNITY NURSES
Nurses working in the community are
often required to commute between visits.
All states and territories in Australia have
laws making it an offence to operate a
vehicle while under the influence of drugs.
These laws allow the police to initiate drug
testing if they suspect a driver of a vehicle is
under the influence of an illicit substance.
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Exposure to medicinal cannabis
through SHCS could lead to the external
contamination of hair, yielding falsepositive results (Baciu et al. 2015).

In addition to this, over the last decade
random roadside drug testing of drivers has
become a common feature on Australian
roads. Road-side drug testing determines
the presence or absence of cannabis, ecstasy
or amphetamines in oral fluid samples
(Wilson 2012). The approach to the results
differs by state.
For example, Queensland Police (2016)
note in their guidelines on random
roadside drug testing ‘any trace of the
nominated drugs in your system and
you can be penalised’. While there is no
universal threshold to differentiate active
smokers from SHCS (Holitzki et al 2017), the
government of South Australia (2017) has
reported the level of THC present in saliva as
a result of passive smoking is considerably
lower than the lowest level of THC able to be
detected by the saliva testing devices. After
a positive result in a drug test, penalties
include fines, licence disqualification and
imprisonment, depending on the nature
of the offence. In addition, the healthcare
registration board may require them to go
through the disciplinary hearing process
because it constitutes a breach of the
professional conduct, as they are under the
influence of illicit substances while on duty.
Importantly for nurses, their registration
may be suspended until the hearing process
is completed.
The advice of Berthet et al. (2016) on
avoiding exposure to cannabis smoke
in unventilated areas has particular
implications for those nurses who have
conditions placed on their registration
as a consequence of substance related
impairment. Australian Health Practitioner
Regulation Agency (AHPRA) and
the Nursing and Midwifery Board of
Australia (NMBA) have drug testing for

Furthermore, SHCS can lead to enough
cannabinoid presence in oral fluids, blood
and urine so as to give a positive result in
a drug test (Holitzki et al. 2017). Therefore,
given the potential impact that SHCS can
have on a nurse, appropriate consideration
should be included in the discussion of
the use of medical cannabis, including
education of the health practitioners on
these aspects.
It should be noted that each state and
territory has its own regulatory frameworks
for the access to medicinal cannabis
(Commonwealth of Australia 2017).
According to the Guidance for the
use of medicinal cannabis in Australia
(Commonwealth of Australia 2017),
nabiximols (an oro-mucosal spray) is
the only registered cannabis product in
Australia.
All other cannabis products must be
accessed through clinical trials and limited
Special Access Schemes, regulated and
monitored by the Therapeutic Goods
Administration (TGA).
In principle, the routes of medicinal
cannabis administration may include oral
administration, oro-mucosal sprays, topical
and vaporising.
However vaporised cannabis may pose
a risk of SHCS to the nurses during the
patient visit, especially as no vaporisers are
currently registered as medical devices in
Australia (Commonwealth of Australia 2017).
The impact of cannabis administered by
routes other than smoking on nurses, and
the use of other cannabis products such as
oils or sprays requires independent analysis.
A final work health and safety factor to
consider is the effect of SHCS on the foetus
in the case of a pregnant nurse. There
are studies that show prenatal exposure
to cannabis is linked to higher rates of
stillbirth, shorter length at birth and
smaller head circumference. Therefore,
there is suspicion that SHCS may have
similar effects on the foetus.
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of a vapour (Queensland Health 2017)
but currently, no vaporisers have been
approved and registered as medical devices
in Australia (Commonwealth of Australia
2017). Therefore, smoking is still the most
common route of administration of
medicinal cannabis. In this case, community
nurses may inhale cannabis substances
while they are carrying out the duty of
care in the patients’ home. Exposure to the
cannabis substances at work may pose some
serious work health and safety issues. This
review found that the effects and impact of
SHCS may include:
• increased risk of cardiovascular
diseases;
• deleterious effects on the foetus if the
nurse is pregnant;
• altered cognitive function leading to
increase the risk of medical errors and
car accident while commuting between
visits;
• risk of drug addiction;

•
•

Abrams, D.I. 2018. The therapeutic effects of Cannabis and
cannabinoids: An update from the National Academies of
Sciences, Engineering and Medicine report. European Journal
of Internal Medicine, 1–5.

Government of South Australia. 2017. Drug Driving FAQS.
Government of South Australia: South Australia.
dpti.sa.gov.au/towardszerotogether/Safer_behaviours/Drug_
driving2/drug_driving_faqs Accessed Jan 2018.

Agrawal, A., Grant, J.D., Lynskey, M.T., Madden, P.A., Heath, A.C.,
Bucholz, K.K. and Sartor, C.E. 2016. The genetic relationship
between cannabis and tobacco cigarette use in European- and
African-American female twins and siblings. Drug Alcohol
Depend, 163(1): 165–171.

Grotenhermen, F. 2003. Pharmacokinetics and
pharmacodynamics of cannabinoids. Clin Pharmacokinet,
42(4): 327–60.

Newmeyer, M.N., Swortwood, M.J., Abulseoud, O.A. and Huestis,
M.A. 2017. Subjective and physiological effects, and expired
carbon monoxide concentrations in frequent and occasional
cannabis smokers following smoked, vaporized, and oral
cannabis administration. Drug and Alcohol Dependence, 175
(Supplement C): 67–76.

In fact, the American College of Obstetrician
and Gynecologists (ACOG) have stated
that there is data of the negative impact on
the foetus of prenatal cannabis exposure
including neurological development, visual
problem solving, visual-motor coordination
and visual analysis, decreased attention
span and behavioural problems. Therefore
since 2015 ACOG has repeatedly warned
obstetricians to deliver the message to
pregnant women not to smoke cannabis or
be exposed to SHCS (Gynecologists 2015).

CONCLUSION:
In Australia, medicinal cannabis has been
a legal treatment modality since 2017 for
several approved medical conditions.
The current available medicinal cannabis
products that may be prescribed and
approved by the TGA include both plantbased and synthetic products. The route
of administration may be in the form

positive road-side drug tests; and
loss of nursing registration due to
misuse of illegal substances.

If a nurse tests positive in a drug test, the
court may impose penalties for the charge.
In addition, it is a breach of the professional
conduct while providing direct patient care
under the influence of illicit substances. The
healthcare registration board may require
them to go through the disciplinary hearing
process. The nurse may be suspended from
work or on restricted duty until the hearing
process is completed.
The use of medicinal cannabis as a
treatment modality is new to Australian
nurses. More research and education are
required in this area to strengthen policies
and procedures around the nursing
practices relating to the care of patients who
choose to use smoked medicinal cannabis to
manage their chronic or terminal medical
conditions.
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